Selecting GLP-1 agonists in the management of type 2 diabetes: differential pharmacology and therapeutic benefits of liraglutide and exenatide

J Pinkney, T Fox, L Ranganath - Therapeutics and clinical risk …, 2010 - Taylor & Francis
Failure of secretion of the incretin hormone glucagon-like peptide-1 (GLP-1) plays a
prominent role in type 2 diabetes, and restoration of GLP-1 action is an important therapeutic …
被引用次数：43 相关文章

Selecting GLP-1 agonists in the management of type 2 diabetes: differential pharmacology and therapeutic benefits of liraglutide and exenatide

J Pinkney, T Fox, L Ranganath - Therapeutics and Clinical …, 2010 - search.proquest.com
Failure of secretion of the incretin hormone glucagon-like peptide-1 (GLP-1) plays a
prominent role in type 2 diabetes, and restoration of GLP-1 action is an important therapeutic …

Selecting GLP-1 agonists in the management of type 2 diabetes: differential pharmacology and therapeutic benefits of liraglutide and exenatide.

J Pinkney, T Fox, L Ranganath - Therapeutics and Clinical Risk …, 2010 - europepmc.org
Failure of secretion of the incretin hormone glucagon-like peptide-1 (GLP-1) plays a
prominent role in type 2 diabetes, and restoration of GLP-1 action is an important therapeutic …
[HTML] nih.gov

[HTML][HTML] Selecting GLP-1 agonists in the management of type 2 diabetes: differential pharmacology and therapeutic benefits of liraglutide and exenatide

J Pinkney, T Fox, L Ranganath - Therapeutics and Clinical Risk …, 2010 - ncbi.nlm.nih.gov
Failure of secretion of the incretin hormone glucagon-like peptide-1 (GLP-1) plays a
prominent role in type 2 diabetes, and restoration of GLP-1 action is an important therapeutic …
[PDF] psu.edu

[PDF][PDF] Selecting GLP-1 agonists in the management of type 2 diabetes: differential pharmacology and therapeutic benefits of liraglutide and exenatide

J Pinkney - Therapeutics and Clinical Risk Management, 2010 - Citeseer
Failure of secretion of the incretin hormone glucagon-like peptide-1 (GLP-1) plays a
prominent role in type 2 diabetes, and restoration of GLP-1 action is an important therapeutic …

Selecting GLP-1 agonists in the management of type 2 diabetes: differential pharmacology and therapeutic benefits of liraglutide and exenatide

J Pinkney - 2010 - pearl.plymouth.ac.uk
Failure of secretion of the incretin hormone glucagon-like peptide-1 (GLP-1) plays a
prominent role in type 2 diabetes, and restoration of GLP-1 action is an important therapeutic …

Selecting GLP-1 agonists in the management of type 2 diabetes: differential pharmacology and therapeutic benefits of liraglutide and exenatide

J Pinkney, T Fox, L Ranganath - Therapeutics and Clinical Risk …, 2010 - dovepress.com
Failure of secretion of the incretin hormone glucagon-like peptide-1 (GLP-1) plays a
prominent role in type 2 diabetes, and restoration of GLP-1 action is an important therapeutic …
[PDF] researchgate.net

[PDF][PDF] Selecting GLP-1 agonists in the management of type 2 diabetes: differential pharmacology and therapeutic benefits of liraglutide and exenatide

J Pinkney - Therapeutics and Clinical Risk Management, 2010 - researchgate.net
Failure of secretion of the incretin hormone glucagon-like peptide-1 (GLP-1) plays a
prominent role in type 2 diabetes, and restoration of GLP-1 action is an important therapeutic …
[PDF] scienceopen.com

[PDF][PDF] Selecting GLP-1 agonists in the management of type 2 diabetes: differential pharmacology and therapeutic benefits of liraglutide and exenatide

J Pinkney - Therapeutics and Clinical Risk Management, 2010 - scienceopen.com
Failure of secretion of the incretin hormone glucagon-like peptide-1 (GLP-1) plays a
prominent role in type 2 diabetes, and restoration of GLP-1 action is an important therapeutic …
[PDF] academia.edu

[PDF][PDF] Selecting GLP-1 agonists in the management of type 2 diabetes: differential pharmacology and therapeutic benefits of liraglutide and exenatide

J Pinkney - Therapeutics and Clinical Risk Management, 2010 - academia.edu
Failure of secretion of the incretin hormone glucagon-like peptide-1 (GLP-1) plays a
prominent role in type 2 diabetes, and restoration of GLP-1 action is an important therapeutic …